Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRL1 | P41146 | 4/20 | 0.41 |
| ▸ | KEAP1 | Q14145 | 5/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.39 |
| ▸ | CCKBR | P32239 | 2/20 | 0.39 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.39 |
| ▸ | TACR3 | P29371 | 1/20 | 0.39 |
| ▸ | QRFPR | Q96P65 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29313371 | 0.99 | OPRL1 (0.39) | OPRL1KEAP1BCL2L1CCKBRCALCRL | |
| SCHEMBL29311719 | 0.94 | CCKBR (0.43) | KEAP1CCKBRTACR3QRFPR | |
| SCHEMBL29311718 | 0.94 | CCKBR (0.43) | KEAP1CCKBRTACR3QRFPR | |
| SCHEMBL27273315 | 0.92 | KEAP1 (0.46) | KEAP1CCKBRTACR3 | |
| SCHEMBL29312729 | 0.92 | KEAP1 (0.46) | KEAP1CCKBRTACR3 | |
| SCHEMBL27274438 | 0.91 | FOLH1 (0.43) | — | |
| SCHEMBL27273419 | 0.91 | FOLH1 (0.43) | — | |
| SCHEMBL29312741 | 0.89 | KEAP1 (0.42) | KEAP1CCKBRTACR3 | |
| SCHEMBL29312765 | 0.89 | KEAP1 (0.42) | KEAP1CCKBRTACR3 | |
| SCHEMBL29313240 | 0.89 | KEAP1 (0.40) | KEAP1CCKBRTACR3QRFPR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | Quantum-Si Incorporated (US) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240228671-A1 | POLYPEPTIDYL LINKERS | VIP, DNPEP, PREP | OPRL1 1480/4885KEAP1 1835/4885BCL2L1 4470/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.